PRESSRELEASES

28 April, 2022

The European Patent Office has granted Nanexa’s PharmaShell® patent

Nanexa AB (publ) today announced that the European Patent Office (EPO) has granted the company’s patent application relating to the drug delivery system PharmaShell®. The patent protection covers the manufacturing method of PharmaShell and products produced using the method.

20 April, 2022

Nanexa publishes interim report for January – March 2022

Positive development in the product projects and in the patent portfolio

LATEST REPORTS

CURRENT

2 maj, 2022

Aktiespararna, Aktiedagen Stockholm



20 mars, 2022

Webcast och frågestund, Delårsrapport jan-mar 2022

NEWSLETTER

Meet Nanexa